[Pirenzepine and cimetidine in the treatment of duodenal ulcer].

M Szathmári, Z Tulassay, L Schandl, J Papp
{"title":"[Pirenzepine and cimetidine in the treatment of duodenal ulcer].","authors":"M Szathmári,&nbsp;Z Tulassay,&nbsp;L Schandl,&nbsp;J Papp","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>The efficacy of pirenzepin--of anticholinergic effect--and the H2-receptor blocking cimetidine has been studied in duodenal ulcer with random, double blind fashion. Recurrence examinations were carried out 6 and 12 months following the treatment. 50 patients were given pirenzepin and 50 cimetidine. The average age of the patients was 44.5 and 43.8 years respectively. Of them 60 (24 + 36) were men and 40 (26 + 14) women. At the start, 6 weeks following the start 6 and 12 months after the finishing of the treatment gastroscopy was performed. In the course of the six-week-long treatment 38 (76%) of the pirenzepin taking patients and 36 (72%) of the cimetidine taking patients recovered. No significant difference was found between the efficacy of the both treatments. In the respect of the half and one year recurrence, no significant difference was observed between the two patient groups. Ten of the patients taking pirenzepin and 4 of those taking cimetidine complained of side effects. Dryness of mouth, visual disturbance in the former group and constipation in the latter one. On the basis of the examinations both secretion inhibitors were found equally suitable for the therapy of duodenal ulcer.</p>","PeriodicalId":11189,"journal":{"name":"Deutsche Zeitschrift fur Verdauungs- und Stoffwechselkrankheiten","volume":"48 2","pages":"75-9"},"PeriodicalIF":0.0000,"publicationDate":"1988-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Deutsche Zeitschrift fur Verdauungs- und Stoffwechselkrankheiten","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The efficacy of pirenzepin--of anticholinergic effect--and the H2-receptor blocking cimetidine has been studied in duodenal ulcer with random, double blind fashion. Recurrence examinations were carried out 6 and 12 months following the treatment. 50 patients were given pirenzepin and 50 cimetidine. The average age of the patients was 44.5 and 43.8 years respectively. Of them 60 (24 + 36) were men and 40 (26 + 14) women. At the start, 6 weeks following the start 6 and 12 months after the finishing of the treatment gastroscopy was performed. In the course of the six-week-long treatment 38 (76%) of the pirenzepin taking patients and 36 (72%) of the cimetidine taking patients recovered. No significant difference was found between the efficacy of the both treatments. In the respect of the half and one year recurrence, no significant difference was observed between the two patient groups. Ten of the patients taking pirenzepin and 4 of those taking cimetidine complained of side effects. Dryness of mouth, visual disturbance in the former group and constipation in the latter one. On the basis of the examinations both secretion inhibitors were found equally suitable for the therapy of duodenal ulcer.

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
[吡仑氮平联合西咪替丁治疗十二指肠溃疡]。
采用随机双盲法研究了具有抗胆碱能作用的匹伦齐平和具有h2受体阻断作用的西咪替丁治疗十二指肠溃疡的疗效。治疗后6个月和12个月进行复发检查。50例患者给予吡伦齐平,50例给予西咪替丁。患者的平均年龄分别为44.5岁和43.8岁。其中男性60例(24 + 36),女性40例(26 + 14)。开始时、开始后6周、治疗结束后6个月及12个月行胃镜检查。在6周的治疗过程中,38例(76%)服用匹伦齐平的患者和36例(72%)服用西咪替丁的患者康复。两种治疗方法的疗效无显著差异。在半年和一年复发率方面,两组患者无显著差异。10名服用匹伦齐平的患者和4名服用西咪替丁的患者抱怨有副作用。前者为口干、视力障碍,后者为便秘。在检查的基础上,发现两种分泌抑制剂同样适用于十二指肠溃疡的治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
[Transepithelial electric potential difference (tPD) in clinical medicine. Methodologic aspects of measuring potential differences in the gastrointestinal tract]. [Hydrochloric acid, pepsin and mucus secretion in the stomach of healthy probands following a single insulin administration with simultaneous pentagastrin infusion]. Enzyme activities of collagen peptidase (CP), monoaminoxidase (MAO) and N-acetyl-beta-D-glucosaminidase (beta-NAG) as fibrosis marker in chronic liver diseases. [The effect of naloxone on basal and maximum gastric secretion in patients with chronic duodenal ulcer]. [Liver morphology and clinical aspects of a case of cholesterol ester storage disease].
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1